InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Korro Bio, Inc.

KRRO Clue Score32
United States Fiscal year ends December CIK 0001703647 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

16
Insider
Date
Role
Action
Shares
Price
Amount
Lynx1 Capital Management LP
26 Oct 2026
10% owner
Buy indirect
25,124
$11.75
$295.09K
Lynx1 Capital Management LP
23 Oct 2026
10% owner
Buy indirect
2,510
$12.11
$30.39K
Lynx1 Capital Management LP
22 Oct 2026
10% owner
Buy indirect
40,000
$11.04
$441.46K
Lynx1 Capital Management LP
22 Oct 2026
10% owner
Buy indirect
12,175
$9.68
$117.81K
Lynx1 Capital Management LP
10 Aug 2026
10% owner
Buy indirect
1,462
$13.19
$19.28K
Lynx1 Capital Management LP
6 Aug 2026
10% owner
Buy indirect
5,222
$11.40
$59.53K
Lynx1 Capital Management LP
31 Mar 2026
10% owner
Buy indirect
520
$10.60
$5.51K
Anthony A. Florence Jr.
10 Mar 2026
10% owner
Buy indirect
207,100
$11.11
$2.30M
Paul Edward Walker
10 Mar 2026
10% owner
Buy indirect
207,100
$11.11
$2.30M
Mohamad Makhzoumi
10 Mar 2026
10% owner
Buy indirect
207,100
$11.11
$2.30M
Edward T Mathers
10 Mar 2026
10% owner
Buy indirect
207,100
$11.11
$2.30M
Forest Baskett
10 Mar 2026
10% owner
Buy indirect
207,100
$11.11
$2.30M
Carmen Chang
10 Mar 2026
10% owner
Buy indirect
207,100
$11.11
$2.30M
New Enterprise Associates 17, L.P.
10 Mar 2026
10% owner
Buy
207,100
$11.11
$2.30M
Scott D Sandell
10 Mar 2026
10% owner
Buy indirect
207,100
$11.11
$2.30M
Rick Yang
10 Mar 2026
10% owner
Buy indirect
207,100
$11.11
$2.30M
Show all 49 transactions →

What was left out

Form 4 filings counted 48
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 27
Sales straight out of an exercise 0
Sales at will 6
Transactions with no price 0
Shares from compensation/vesting 429,331
History held since 2 Oct 2019